论文部分内容阅读
目的分析探讨乌司他丁联合奥曲肽治疗胰腺炎的有效性和不良反应。方法 76例胰腺炎患者,使用数字抽签法分成实验组和对照组,每组38例。对照组给予奥曲肽治疗,实验组给予奥曲肽联合乌司他丁治疗,并在两组患者治疗结束后,对比其治疗效果和不良反应率。结果实验组的治疗总有效率为94.74%,高于对照组的73.68%(P<0.05);两组均未出现明显的不良反应情况。结论乌司他丁联合奥曲肽治疗胰腺炎具有显著的有效性,且安全性较高,值得在临床中应用和推广。
Objective To investigate the efficacy and adverse reactions of ulinastatin combined with octreotide in the treatment of pancreatitis. Methods 76 patients with pancreatitis were divided into experimental group and control group by digital lottery method, with 38 cases in each group. The control group received octreotide treatment, the experimental group was given octreotide combined with ulinastatin treatment, and in the two groups of patients after treatment, compared with the treatment effect and adverse reaction rate. Results The total effective rate of the experimental group was 94.74%, which was higher than that of the control group (73.68%) (P <0.05). No obvious adverse reactions occurred in both groups. Conclusion ulinastatin combined with octreotide in the treatment of pancreatitis has significant efficacy, and high safety, it is worth in the clinical application and promotion.